Lake Erie College of Osteopathic Medicine (LECOM) is reinforcing its commitment to accessible and affordable pharmacy ...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
April 14, 2026 - PRESSADVANTAGE - All Pro Gutter Guards has announced the expansion of its service line to include ...
A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
New York, New York - April 15, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has announced an overview of its AI ...
Researchers have developed a rapid color-changing test that can distinguish between different strains of golden staph, ...
The success of the Women’s Health Strategy will depend on whether innovation can be adopted at scale, writes Dr MaryAnn Ferreux ...
Announcing the launch of Good Jobs Western North Carolina, workforce tools to support state leaders, and new private and philanthropic investments SAN DIEGO, April 14, 2026 /PRNewswire/ -- Today at ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced new in vitro findings demonstrating that izicopan ...
The addition of TeraVERSE to Molex's comprehensive optical interconnect portfolio provides customers with greater support across their CPO and silicon photonics architectures. As a leader in ...
Microbial infections, caused by bacteria, viruses, and parasites, pose a significant challenge to global health, affecting millions annually. Despite advancements in medical science, understanding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results